Monday, December 23, 2024
HomeTagsBemcentinib's

bemcentinib's

Bergenbio Announces Launch of Business Strategy Focused On Nsclc and COVID-19

BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announces today an update on its business...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics